0000950170-23-064616.txt : 20231116 0000950170-23-064616.hdr.sgml : 20231116 20231116193145 ACCESSION NUMBER: 0000950170-23-064616 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231114 FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tammenoms Bakker Juliet CENTRAL INDEX KEY: 0001431159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40690 FILM NUMBER: 231416070 MAIL ADDRESS: STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC STREET 2: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RxSight, Inc. CENTRAL INDEX KEY: 0001111485 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 943268801 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLUMBIA STREET STREET 2: SUITE 120 CITY: ALISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 949-521-7822 MAIL ADDRESS: STREET 1: 100 COLUMBIA STREET STREET 2: SUITE 120 CITY: ALISO VIEJO STATE: CA ZIP: 92656 FORMER COMPANY: FORMER CONFORMED NAME: CALHOUN VISION INC DATE OF NAME CHANGE: 20000410 4 1 ownership.xml 4 X0508 4 2023-11-14 0001111485 RxSight, Inc. RXST 0001431159 Tammenoms Bakker Juliet C/O RXSIGHT, INC. 100 COLUMBIA ALISO VIEJO CA 92656 true false false false false Common Stock 2023-11-14 4 S false 100000 27.1259 D 894313 I See footnote Common Stock 2023-11-15 4 S false 400000 27.1954 D 494313 I See footnote Common Stock 445400 I See footnote Common Stock 855 I See footnote Common Stock 20223 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.79 to $27.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 1 to this Form 4. These securities are held directly by Longitude Venture Partners II, L.P. ("LVP II"). Longitude Capital Partners II, LLC ("LCP II"), the general partner of LVP II, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LCP II and may be deemed to share voting, investment and dispositive power over such securities. Each of LVP II, LCP II, Mr. Enright and the Reporting Person disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.935 to $27.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 3 to this Form 4. The securities are held directly by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP"), the general partner of LPF, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, and Mr. Enright are the managing members of LPP and may be deemed to share voting, investment and dispositive power over such securities. Each of LPF, LPP, Mr. Enright and the Reporting Person disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. /s/ Cristiana Blauth Oliveira as Attorney-in-fact for Juliet Tammenoms Bakker 2023-11-16